Waldenstrom macroglobulinemia
Showing 476 - 500 of 503
Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial run by the CC (biological, drug, other)
Completed
- Lung Cancer
- +4 more
- bevacizumab
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012
Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Atlanta (biological, drug, procedure)
Terminated
- Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +5 more
-
Atlanta, GeorgiaBlood and Marrow Transplant Group of Georgia
Mar 19, 2012
Leukemia, Lymphoma Trial in Seattle (drug, procedure, radiation)
Completed
- Leukemia
- Lymphoma
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Nov 28, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +4 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Dec 7, 2011
Quality of Life in Younger Leukemia and Lymphoma Survivors
Completed
- Anxiety Disorder
- +9 more
- telephone-based intervention
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Aug 23, 2011
Waldenstrom Macroglobulinemia Trial in Little Rock (Thalidomide)
Completed
- Waldenstrom Macroglobulinemia
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences/MIRT
Jul 1, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (aldesleukin, recombinant interferon alfa)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- aldesleukin
- recombinant interferon alfa
-
Newport Beach, California
- +4 more
May 10, 2011
Lymphoma, Solid Tumor Trial in Nashville (oxaliplatin, pemetrexed disodium)
Completed
- Lymphoma
- Solid Tumor
- oxaliplatin
- pemetrexed disodium
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Apr 14, 2011
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (fluorouracil, leucovorin calcium, topotecan HCl)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- fluorouracil
- +2 more
-
New York, New YorkKaplan Cancer Center
Mar 25, 2011
Cancer Trial in London, Edinburgh, Glasgow (drug, other, procedure)
Unknown status
- Cancer
- ketamine hydrochloride
- +4 more
-
London, England, United Kingdom
- +2 more
May 12, 2011
Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer Trial in Buffalo (Src kinase inhibitor KX2-391, immunoenzyme
Completed
- Lymphoma
- +3 more
- Src kinase inhibitor KX2-391
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2011
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +72 more
- busulfan
- +5 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Aug 5, 2010
Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer Trial in La Jolla (sargramostim, amifostine trihydrate,
Completed
- Breast Cancer
- +5 more
- sargramostim
- +4 more
-
La Jolla, CaliforniaScripps Clinic
Jan 6, 2011
Lymphoma Trial in Philadelphia (biological, drug, procedure, radiation)
Completed
- Lymphoma
- filgrastim
- +5 more
-
Philadelphia, PennsylvaniaTemple University Cancer Center
Sep 30, 2010
Anemia, Leukemia, Lymphoma Trial in Scottsdale, Rochester (biological, dietary supplement, drug, other)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- +3 more
-
Scottsdale, Arizona
- +1 more
May 13, 2011
Cancer Trial in Seattle (methotrexate, methylprednisolone, prednisone)
Completed
- Cancer
- methotrexate
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Sep 10, 2010
Leukemia, Lymphoma, Solid Tumor Trial in Baltimore (7-hydroxystaurosporine)
Completed
- Leukemia
- +2 more
-
Baltimore, MarylandJohns Hopkins Oncology Center
Aug 5, 2010
Leukemia, Lymphoma Trial run by the (BL22 immunotoxin, antibody-drug conjugate therapy, immunotoxin therapy)
Completed
- Leukemia
- Lymphoma
- BL22 immunotoxin
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Jun 17, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Seattle (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- cyclophosphamide
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 31, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- monoclonal antibody A27.15
- monoclonal antibody E2.3
-
Tucson, ArizonaArizona Cancer Center
Mar 12, 2010
Leukemia, Lymphoma Trial in New York, Philadelphia, Richmond (bryostatin 1, fludarabine phosphate)
Completed
- Leukemia
- Lymphoma
- bryostatin 1
- fludarabine phosphate
-
New York, New York
- +2 more
Feb 23, 2010
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New Brunswick (tetradecanoylphorbol acetate)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- tetradecanoylphorbol acetate
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Jan 25, 2010
Lymphoma Trial in United States (denileukin diftitox)
Completed
- Lymphoma
- denileukin diftitox
-
Chicago, Illinois
- +9 more
Jan 26, 2010